Liliana Maruri Avidal

Title: Liliana Maruri Avidal: Innovator in Oncolytic Vaccinia Virus Research

Introduction

Liliana Maruri Avidal is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of immunotherapy, particularly through her work on recombinant vaccinia viruses. With a total of 2 patents, her innovations are paving the way for new treatments in oncology.

Latest Patents

Liliana's latest patents include groundbreaking work on recombinant vaccinia viruses. The first patent details a replication-competent, recombinant oncolytic vaccinia virus, along with compositions that utilize this virus. This innovation aims to induce oncolysis in individuals with tumors. The second patent reiterates the same focus on the replication-competent, recombinant oncolytic vaccinia virus and its applications in cancer treatment.

Career Highlights

Liliana is currently associated with Ignite Immunotherapy, Inc., where she continues to advance her research in the field. Her work is characterized by a commitment to developing effective therapies for cancer patients.

Collaborations

Throughout her career, Liliana has collaborated with notable professionals in her field, including David H. Kirn and Prajit Limsirichai. These collaborations have further enriched her research and contributed to her innovative projects.

Conclusion

Liliana Maruri Avidal stands out as a key figure in the development of oncolytic therapies, with her patents reflecting her dedication to improving cancer treatment. Her work at Ignite Immunotherapy, Inc. continues to inspire advancements in the field of immunotherapy.